Chester Zygmont
Finanzdirektor/CFO bei REVELATION BIOSCIENCES, INC.
Vermögen: 1 276 $ am 31.05.2024
Profil
Chester S.
Zygmont is the founder of Ooxesis Biotech LLC.
He currently holds the position of Chief Financial Officer & Director at Revelation Therapeutics LLC and Secretary, Chief Financial & Accounting Officer at Revelation Biosciences, Inc. Previously, he worked as a Senior Director-Finance at La Jolla Pharmaceutical Co. from 2012 to 2016 and as a Managing Director at Z3 Capital LLC from 2009 to 2012.
He also held the position of Vice President at Symmetry Advisors.
Mr. Zygmont completed his undergraduate degree at Eastern University and his graduate degree at Zicklin School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.04.2024 | 661 ( 0,04% ) | 1 276 $ | 31.05.2024 |
Aktive Positionen von Chester Zygmont
| Unternehmen | Position | Beginn |
|---|---|---|
| REVELATION BIOSCIENCES, INC. | Finanzdirektor/CFO | 01.05.2020 |
Revelation Therapeutics LLC
 Revelation Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Revelation Therapeutics LLC provides biotechnology services. The company is headquartered in Menlo Park, CA. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Chester Zygmont
| Unternehmen | Position | Ende |
|---|---|---|
| Ooxesis Biotech LLC | Gründer | 30.10.2021 |
| LA JOLLA PHARMACEUTICAL COMPANY | Finanzdirektor/CFO | 01.01.2016 |
Z3 Capital LLC
 Z3 Capital LLC Real Estate Investment TrustsFinance Z3 Capital LLC provides real estate investment services. | Corporate Officer/Principal | 01.06.2012 |
Symmetry Advisors
 Symmetry Advisors Investment ManagersFinance Symmetry Advisors provides investment advisory services. The private company is based in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Chester Zygmont
| Eastern University | Undergraduate Degree |
| Zicklin School of Business | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REVELATION BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Symmetry Advisors
Symmetry Advisors Investment ManagersFinance Symmetry Advisors provides investment advisory services. The private company is based in San Diego, CA. | Finance |
| Ooxesis Biotech LLC | |
Z3 Capital LLC
Z3 Capital LLC Real Estate Investment TrustsFinance Z3 Capital LLC provides real estate investment services. | Finance |
Revelation Therapeutics LLC
Revelation Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Revelation Therapeutics LLC provides biotechnology services. The company is headquartered in Menlo Park, CA. | Commercial Services |
